Skip to main content
. 2020 Oct 29;4(12):bvaa160. doi: 10.1210/jendso/bvaa160

Table 1.

Underlying causes of hypopituitarism in the study population

Diagnosis Switch group (n = 105) CA control group(n = 31) AS control group (n = 93)
Nonfunctioning pituitary adenoma 44 (41.9) 5 (16.1) 35 (37.6)
Craniopharyngioma 16 (15.2) 6 (19.4) 5 (5.4)
Idiopathic 7 (6.7) 2 (6.5) 9 (9.7)
Cushing disease 6 (5.7) 4 (12.9) 4 (4.3)
Prolactinoma 6 (5.7) 5 (16.1) 10 (10.8)
Empty sella syndrome 5 (4.8) 0 (0.0) 3 (3.2)
Acromegaly 4 (3.8) 0 (0.0) 7 (7.5)
Other diagnosis 17 (16.2) 9 (29.0) 20 (21.5)
Other diagnosis (n = 17) (n = 9) (n = 20)
 Congenital hypopituitarism 2 - 1
 Cystic change 1 - -
 Dysgerminoma 1 - -
 Ependymoma - 1 1
 Granular cell tumor - - 1
 Histiocytosis - 1 -
 Hypophysitis 2 2 1
 Isolated idiopathic GHD - - 5
 Leukemia - - 2
 Medulloblastoma - - 1
 Meningioma 2 1 3
 Pituitary apoplexia 1 1 1
 Rhabdomyosarcoma - - 1
 Sarcoidosis 1 1 -
 Septo-optic dysplasia - 1 -
 Sheehan syndrome 2 - -
 Trauma 3 - 1
 Unknown 2 1 2

Data are given as No. (%).

Abbreviations: AS, adrenal sufficient; CA, cortisone acetate; GHD, growth hormone deficiency.